FAME - Fampyra outcome measures study: a study of responsiveness of different outcome measures to Fampyra treatment.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2015
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms FAME
- 02 Nov 2012 Planned End Date changed from 15 Feb 2015 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 02 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Aug 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01656148).